Milestone Scientific price to free cash flow MLSS
Market value divided by free cash flow over the last twelve months, since 2013.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 178×
- May 2015
- Peer median
- 15.2×
Milestone Scientific's price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.
It was last meaningful in May 2015, at 178×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2015 | 178× | 67.1× | 204× |
| 2014 | 70.0× | 18.0× | 96.5× |
| 2013 | 84.5× | 75.0× | 434× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Milestone Scientific's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| MLSSMilestone Scientific | n/m |
| NEPHNephros | n/m |
| APTAlpha Pro Tech | 9.7× |
| KEQUKewaunee Scientific | 8.7× |
| PDEXPro DEX | 29.5× |
| UTMDUtah Medical Products | 20.6× |
| Peer median | 15.2× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Milestone Scientific
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.